Updates are available Correction dated 2024-01-03
Click to view Correction: https://doi.org/10.1038/s41596-023-00952-2
-
Authors
Li, Shuo https://orcid.org/0000-0002-1960-6016
Hu, Ran https://orcid.org/0000-0002-0563-8957
Small, Colin
Kang, Ting-Yu
Liu, Chun-Chi
Zhou, Xianghong Jasmine
Li, Wenyuan https://orcid.org/0000-0002-5029-8525
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA230705, R01CA264864, R01CA246329, R01CA246329, U01CA237711)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 25 April 2022
Accepted: 24 November 2022
First Online: 27 February 2023
Change Date: 3 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41596-023-00952-2
Competing interests
: X.J.Z. and W.L. are co-founders of EarlyDiagnostics Inc. X.J.Z. serves on the Board of Directors and has an executive leadership position at EarlyDiagnostics. C.-C.L. and T.-Y.K. are employees of EarlyDiagnostics. X.J.Z. and W.L. are stockholders of EarlyDiagnostics. S.L., C.-C.L. have stock options with EarlyDiagnostics. W.L. is a consultant for EarlyDiagnostics. X.J.Z., S.L. and W.L. are inventors on a patent application submitted by the Regents of the University of California and licensed to EarlyDiagnostics (patent no. US20210125683A1). The remaining authors declare no competing interests.
